|
Market Closed -
Nasdaq
16:00:00 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 7.500 USD | -2.98% |
|
-11.76% | -28.57% |
| 10-02 | Nanobiotix Names New Finance Chief | MT |
| 10-01 | Nanobiotix Appoints Arnd Christ as CFO | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMATICS N.V. | Bio Therapeutic Drugs | -2.98% | -11.76% | -28.57% | -20.21% | -42.31% | 1.06B |  | | |
- Stock Market
- Stocks
- IMTX Stock
- Charts Immatics N.V.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
